首页> 外文期刊>Journal of immunology research. >The Inhibitory Role of B7-H4 in Antitumor Immunity: Association with Cancer Progression and Survival
【24h】

The Inhibitory Role of B7-H4 in Antitumor Immunity: Association with Cancer Progression and Survival

机译:B7 H4在抗肿瘤免疫中的抑制作用:与癌症进展和生存的关联。

获取原文
           

摘要

B7-H4 is one of the most recently identified members of B7 superfamily of costimulatory molecules serving as an inhibitory modulator of T-cell response. B7-H4 is broadly expressed in human peripheral tissues and inducibly expressed in immune cells. The expression of B7-H4 has been observed in various types of human cancer tissues, and its soluble form has been detected in blood samples from cancer patients. However, its precise physiological role is still elusive, as its receptor has not been identified and the expression levels are not consistent. This paper summarizes the pertinent data on the inhibitory role of B7-H4 in antitumor immunity and its association with cancer progression and survival in human patients. The paper also discusses the clinical significance of investigating B7-H4 as potential markers for cancer diagnosis and prognosis, and as therapeutic targets.
机译:B7-H4是共刺激分子B7超家族中最近鉴定的成员之一,可作为T细胞反应的抑制性调节剂。 B7-H4在人周围组织中广泛表达,并在免疫细胞中诱导表达。已经在各种类型的人类癌症组织中观察到B7-H4的表达,并且已经在来自癌症患者的血液样本中检测到其可溶形式。但是,由于其受体尚未确定且表达水平不一致,其确切的生理作用仍然难以捉摸。本文总结了有关B7-H4在抗肿瘤免疫中的抑制作用及其与人类患者癌症进展和生存的关系的相关数据。本文还讨论了研究B7-H4作为癌症诊断和预后的潜在标志物以及治疗靶标的临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号